Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization

The discovery of drugs capable of inhibiting SARS-CoV-2 is a priority for human beings due to the severity of the global health pandemic caused by COVID-19. To this end, repurposing of FDA-approved drugs such as NSAIDs against COVID-19 can provide therapeutic alternatives that could be utilized as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Abo Elmaaty, Ayman, Hamed, Mohammed I. A., Ismail, Muhammad I., B. Elkaeed, Eslam, S. Abulkhair, Hamada, Khattab, Muhammad, Al-Karmalawy, Ahmed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234583/
https://www.ncbi.nlm.nih.gov/pubmed/34205704
http://dx.doi.org/10.3390/molecules26123772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234583/
https://www.ncbi.nlm.nih.gov/pubmed/34205704
http://dx.doi.org/10.3390/molecules26123772

Ejemplares similares